Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $256.89 million. The enterprise value is $325.59 million.
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 66.12 million shares outstanding. The number of shares has increased by 65.99% in one year.
| Current Share Class | 66.12M |
| Shares Outstanding | 66.12M |
| Shares Change (YoY) | +65.99% |
| Shares Change (QoQ) | +7.67% |
| Owned by Insiders (%) | 5.90% |
| Owned by Institutions (%) | 26.66% |
| Float | 37.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.70 |
| Forward PS | 2.12 |
| PB Ratio | 9.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 2.56.
| Current Ratio | 2.02 |
| Quick Ratio | 1.34 |
| Debt / Equity | 2.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.77 |
Financial Efficiency
Return on equity (ROE) is -190.79% and return on invested capital (ROIC) is -24.25%.
| Return on Equity (ROE) | -190.79% |
| Return on Assets (ROA) | -20.34% |
| Return on Invested Capital (ROIC) | -24.25% |
| Return on Capital Employed (ROCE) | -35.26% |
| Revenue Per Employee | $155,176 |
| Profits Per Employee | -$68,154 |
| Employee Count | 716 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 8.68 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +421.48% in the last 52 weeks. The beta is 1.78, so Neuronetics's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | +421.48% |
| 50-Day Moving Average | 3.85 |
| 200-Day Moving Average | 3.19 |
| Relative Strength Index (RSI) | 43.61 |
| Average Volume (20 Days) | 1,279,456 |
Short Selling Information
The latest short interest is 4.75 million, so 7.18% of the outstanding shares have been sold short.
| Short Interest | 4.75M |
| Short Previous Month | 4.71M |
| Short % of Shares Out | 7.18% |
| Short % of Float | 12.68% |
| Short Ratio (days to cover) | 5.39 |
Income Statement
In the last 12 months, Neuronetics had revenue of $111.11 million and -$48.80 million in losses. Loss per share was -$1.00.
| Revenue | 111.11M |
| Gross Profit | 62.99M |
| Operating Income | -37.67M |
| Pretax Income | -27.54M |
| Net Income | -48.80M |
| EBITDA | -34.99M |
| EBIT | -37.67M |
| Loss Per Share | -$1.00 |
Full Income StatementBalance Sheet
The company has $10.97 million in cash and $80.66 million in debt, giving a net cash position of -$69.69 million or -$1.05 per share.
| Cash & Cash Equivalents | 10.97M |
| Total Debt | 80.66M |
| Net Cash | -69.69M |
| Net Cash Per Share | -$1.05 |
| Equity (Book Value) | 31.51M |
| Book Value Per Share | 0.41 |
| Working Capital | 28.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.51 million and capital expenditures -$946,000, giving a free cash flow of -$35.46 million.
| Operating Cash Flow | -34.51M |
| Capital Expenditures | -946,000 |
| Free Cash Flow | -35.46M |
| FCF Per Share | -$0.54 |
Full Cash Flow StatementMargins
Gross margin is 56.69%, with operating and profit margins of -33.90% and -43.92%.
| Gross Margin | 56.69% |
| Operating Margin | -33.90% |
| Pretax Margin | -43.70% |
| Profit Margin | -43.92% |
| EBITDA Margin | -31.49% |
| EBIT Margin | -33.90% |
| FCF Margin | n/a |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -65.99% |
| Shareholder Yield | -65.99% |
| Earnings Yield | -19.07% |
| FCF Yield | -13.86% |
Analyst Forecast
The average price target for Neuronetics is $5.67, which is 45.95% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.67 |
| Price Target Difference | 45.95% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 29.83% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -3.64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.64 |
| Piotroski F-Score | 2 |